WallStreetZenWallStreetZen

NASDAQ: CUE
Cue Biopharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CUE

Based on 3 analysts offering 12 month price targets for Cue Biopharma Inc.
Min Forecast
$8.00+238.98%
Avg Forecast
$11.00+366.1%
Max Forecast
$15.00+535.59%

Should I buy or sell CUE stock?

Based on 3 analysts offering ratings for Cue Biopharma Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CUE stock forecasts and price targets.

CUE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Oppenheimer
Bottom 11%
11
BuyAssumes$10.00+323.73%2023-06-26
Stifel Nicolaus
Bottom 4%
4
Strong BuyReiterates$8.00+238.98%2023-06-15
JMP Securities
Bottom 3%
3
BuyReiterates$15.00+535.59%2023-05-15

1 of 1

Forecast return on equity

Is CUE forecast to generate an efficient return?
Company
N/A
Industry
0.6%
Market
28.78%

Forecast return on assets

Is CUE forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.1%

CUE revenue growth forecast

How is CUE forecast to perform vs Biotechnology companies and vs the US market?
Company
136.4%
Industry
35.17%
Market
8.14%
CUE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CUE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CUE vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CUE$2.36$11.00+366.10%Strong Buy
RVPH$4.70$14.25+203.19%Strong Buy
ORMP$2.65$2.00-24.53%Hold
CDXS$1.51$8.50+462.91%Strong Buy
KOD$2.04$5.20+154.90%Hold
View Top Biotech Stocks

Cue Biopharma Stock Forecast FAQ

Is Cue Biopharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CUE) stock is to Strong Buy CUE stock.

Out of 3 analysts, 1 (33.33%) are recommending CUE as a Strong Buy, 2 (66.67%) are recommending CUE as a Buy, 0 (0%) are recommending CUE as a Hold, 0 (0%) are recommending CUE as a Sell, and 0 (0%) are recommending CUE as a Strong Sell.

If you're new to stock investing, here's how to buy Cue Biopharma stock.

What is CUE's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CUE) forecast ROE is N/A, which is considered weak.

What is CUE's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CUE price target, the average CUE price target is $11.00, with the highest CUE stock price forecast at $15.00 and the lowest CUE stock price forecast at $8.00.

On average, Wall Street analysts predict that Cue Biopharma's share price could reach $11.00 by Jun 26, 2024. The average Cue Biopharma stock price prediction forecasts a potential upside of 366.1% from the current CUE share price of $2.36.

What is CUE's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CUE) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.1%.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.